Targeting the Tumor Microenvironment in Neuroblastoma: Recent Advances and Future Directions

por Joshi, Shweta
Publicado 2020

Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy

por Joshi, Shweta, Sharabi, Andrew
Publicado 2022

Combinatorial Approach to Improve Cancer Immunotherapy: Rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System

por Joshi, Shweta, Durden, Donald L.
Publicado 2019

“Re-educating” Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma

por Liu, Kevin X., Joshi, Shweta
Publicado 2020

A PKC-SHP1 signaling axis desensitizes Fcγ receptor signaling by reducing the tyrosine phosphorylation of CBL and regulates FcγR mediated phagocytosis

por Joshi, Shweta, Singh, Alok Ranjan, Zulcic, Muamera, Durden, Donald L
Publicado 2014

Anti-tumor effect of a novel PI3-kinase inhibitor, SF1126, in (12) V-Ha-Ras transgenic mouse glioma model

por Singh, Alok R, Joshi, Shweta, George, Elizabeth, Durden, Donald L
Publicado 2014

Perioperative Challenges in the Management of Rhino-Orbital Cerebral Mucormycosis: An Observational Study from a Tertiary Care Hospital

por Bhalerao, Pradnya Milind, Kuttarmare, Shital Mahendra, Joshi, Shweta, Naik, Sanyogita Vijay
Publicado 2022

Incapacity in childbirth – Rare or common?

por Singh, Neelam, Lepping, Peter, Whitaker, Rhiannon, Masood, Barkat, Joshi, Shweta, Banfield, Philip
Publicado 2021

BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma

por Ishfaq, Mehreen, Pham, Timothy, Beaman, Cooper, Tamayo, Pablo, Yu, Alice L., Joshi, Shweta
Publicado 2021

Immediate post-operative pain in anterior cruciate ligament reconstruction surgery with bone patellar tendon bone graft versus hamstring graft

por Gupta, Ravi, Kapoor, Dheeraj, Kapoor, Love, Malhotra, Anubhav, Masih, Gladson David, Kapoor, Anil, Joshi, Shweta
Publicado 2016

Rac2 Controls Tumor Growth, Metastasis and M1-M2 Macrophage Differentiation In Vivo

por Joshi, Shweta, Singh, Alok R., Zulcic, Muamera, Bao, Lei, Messer, Karen, Ideker, Trey, Dutkowski, Janusz, Durden, Donald L.
Publicado 2014

Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype

por Joshi, Shweta, Singh, Alok R., Wong, Simon S., Zulcic, Muamera, Jiang, Min, Pardo, Annie, Selman, Moises, Hagood, James S., Durden, Donald L.
Publicado 2017

The BTK/PI3K/BRD4 axis inhibitor SRX3262 overcomes Ibrutinib resistance in mantle cell lymphoma

por Pal, Dhananjaya, Vann, Kendra R., Joshi, Shweta, Sahar, Namood E., Morales, Guillermo A., El-Gamal, Dalia, Kutateladze, Tatiana G., Durden, Donald L.
Publicado 2021

Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma

por Rohila, Deepak, Park, In Hwan, Pham, Timothy V., Jones, Riley, Tapia, Elisabette, Liu, Kevin X., Tamayo, Pablo, Yu, Alice, Sharabi, Andrew B., Joshi, Shweta
Publicado 2023

A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity

por Burgoyne, Adam M., Vann, Kendra R., Joshi, Shweta, Morales, Guillermo A., Vega, Francisco M., Singh, Alok, Pal, Dhananjaya, Merati, Aran B., Kutateladze, Tatiana G., Durden, Donald L.
Publicado 2020

Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma

por Rohila, Deepak, Park, In Hwan, Pham, Timothy V., Weitz, Jonathan, Hurtado de Mendoza, Tatiana, Madheswaran, Suresh, Ishfaq, Mehreen, Beaman, Cooper, Tapia, Elisabette, Sun, Siming, Patel, Jay, Tamayo, Pablo, Lowy, Andrew M., Joshi, Shweta
Publicado 2023

PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma

por Singh, Alok R., Joshi, Shweta, Zulcic, Muamera, Alcaraz, Michael, Garlich, Joseph R., Morales, Guillermo A., Cho, Yoon J., Bao, Lei, Levy, Michael L., Newbury, Robert, Malicki, Denise, Messer, Karen, Crawford, John, Durden, Donald L.
Publicado 2016

Association of high microvessel α(v)β(3) and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126

por Erdreich-Epstein, Anat, Singh, Alok R., Joshi, Shweta, Vega, Francisco M., Guo, Pinzheng, Xu, Jingying, Groshen, Susan, Ye, Wei, Millard, Melissa, Campan, Mihaela, Morales, Guillermo, Garlich, Joseph R., Laird, Peter W., Seeger, Robert C., Shimada, Hiroyuki, Durden, Donald L.
Publicado 2016

Regulatory de novo mutations underlying intellectual disability

por De Vas, Matias G, Boulet, Fanny, Joshi, Shweta S, Garstang, Myles G, Khan, Tahir N, Atla, Goutham, Parry, David, Moore, David, Cebola, Inês, Zhang, Shuchen, Cui, Wei, Lampe, Anne K, Lam, Wayne W, Ferrer, Jorge, Pradeepa, Madapura M, Atanur, Santosh S
Publicado 2023